Submit a manuscript Sign up for article alerts Contact us Support

About Genome Integrity

This page includes information about the aims and scope of Genome Integrity, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Genome Integrity is an open access journal that publishes research on all aspects of genome integrity, the cellular processes underlying maintenance of genome stability, and the effects of instability.

The processes that regulate genome integrity maintenance include sensing, signalling and repair of DNA damage, processing of DNA damage in the context of chromatin and chromosomes, cell cycle checkpoint control and control of apoptosis. Effective maintenance of genome integrity is essential for normal cell division, tissue homeostasis, healthy organismal ageing and prevention of diseases such as cancer. A number of model systems including single cell organisms and various higher plant and animal species, as well as studies of human cells/tissues or patients are required to understand how genome integrity maintenance affects ageing and development of cancer.

The average time from submission to a first decision is 28 days.

The journal is focused on understanding the processes that regulate the maintenance of genome integrity. Topics include, but are not limited to:

  • induction of DNA damage
  • sensing, signalling and repair of DNA damage
  • processing of DNA damage in the context of chromatin and interphase chromosomes
  • metaphase chromosome alterations
  • telomere maintenance
  • cell cycle regulation
  • control of apoptosis
  • effects of genotoxic stress including radiation and chemicals
  • genome integrity and ageing
  • genome integrity and cancer

Open access

All articles published by Genome Integrity are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in Genome Integrity are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. Genome Integrity therefore levies an article-processing charge of £1170/$1960/€1410 for each article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.

Indexing services

All articles published in Genome Integrity are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Genome Integrity include:

  • Citebase
  • DOAJ
  • Google Scholar
  • Index Copernicus
  • OAIster
  • PubMed
  • PubMed Central
  • Scirus
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

BioMed Central is working closely with Thomson Reuters (ISI) to ensure that citation analysis of articles published in Genome Integrity will be available.

Publication and peer review process

Criteria for publication

Genome Integrity considers the following types of articles:

  • Research: reports of data from original research.
  • Short reports: brief reports of data from original research.
  • Reviews: comprehensive, authoritative, descriptions of any subject within the scope of Genome Integrity. Reviews can cover any topical themes such as basic science and clinical reviews, ethics, pro/con debates, equipment reviews and thematic series to highlight specific topics in the field. They are often written by experts in the field, invited by the Editorial Board.
  • Commentaries: short, focused and opinionated articles on any subject within the scope of Genome Integrity. These articles are usually related to a contemporary issue, such as recent research findings, and may be commissioned from opinion leaders in the field.

Peer-review policies

After being screened for suitability, manuscripts submitted to Genome Integrity will be reviewed by two experts selected by the Editors, with the aim of reaching a decision as soon as possible. Reviewers will be required to declare any competing interests and will be asked to submit their reports within two weeks. Overall the Editors of Genome Integrity aim to reach a decision on a manuscript within six weeks.

After receipt of the recommendation from the reviewers, the Editors-in-Chief will decide whether to accept (outright or subject to revisions) or reject manuscripts. The authors are then given three months with which to revise their manuscript.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Genome Integrity, a personalized section of the site.

Reprints

High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.

Supplements

Genome Integrity will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to Genome Integrity should adhere to BioMed Central's editorial policies.

Citing articles in Genome Integrity

Articles in Genome Integrity should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Genome Integr [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Genome Integr 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Genome Integrity?

High visibility

Genome Integrity's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Genome Integrity offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Genome Integrity, BioMed Central and PubMed Central and will also be included in PubMed.

Flexibility

Online publication in Genome Integrity gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Genome Integrity are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Genome Integrity's pages and on the BioMed Central homepage.

In addition, articles published in Genome Integrity may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Genome Integrity. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in Genome Integrity retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.